Abstract: Neutrophils are a major source of reactive oxygen species (ROS). The role of airway mucous on ROS production is unknown. The aim of our study was to investigate the direct influence of bronchoalveolar lavage fluid (BALF) and induced sputum (IS) alone or in combination with chemical/biological stimulus on ROS production in peripheral blood neutrophils during chronic obstructive pulmonary disease (COPD). Neutrophils were isolated from peripheral blood of 47 patients with moderate COPD and 14 healthy individuals (HI). BALF/RPMI (1:1) or IS/RPMI (1:1) from COPD patients were used to stimulate neutrophils alone or in combination with phorbolmyristate-acetate (PMA) (0.1-30 nM) or Staphylococcus aureus bacteria (0.7-500 bact/neutrophil). Relative generation of ROS was measured flow cytometrically. BALF/RPMI and in combination with relatively low PMA or all bacteria concentrations stimulated ROS; while, combination with relatively high PMA concentrations suppressed ROS in of COPD patients and HI. IS/RPMI and its combination with PMA inhibited ROS generation in both groups; whereas, IS stimulated or had a tendency to stimulate ROS production with relatively high bacteria concentrations. In conclusion, BALF and IS directly or in combination with chemical/biological factors modulated ROS production. This effect was stronger in neutrophils from COPD patients and depended on chemical/biological stimulus intensity.
Introduction
Chronic obstructive pulmonary disease (COPD), characterized by not fully reversible airflow limitation and abnormal inflammatory response of the lungs, is one of the leading causes of mortality in the world [1] . Oxidative stress in the form of reactive oxygen species (ROS) plays a major role in the pathogenesis of COPD and is much related with an inflammatory response [2, 3] . ROS are defined as unstable molecules with unpaired electrons, capable to initiate the oxidation of proteins, lipids and DNA. It may also cause a direct tissue injure or induce a variety of cellular responses, through the generation of secondary metabolic reactive species [3, 4] . A small amount of ROS is essential for cell protection, viability and apoptosis, but an intensive ROS production is capable to mediate various damages of cell and tissue.
A major source and producers of ROS are activated neutrophils [5] , which are necessary cell type in the circulation and tissues of healthy individuals (HI). They are the principal effectors of antibody and complementmediated immune responses. Despite their protective role, neutrophils are also implicated in the pathogenesis of chronic inflammatory process, COPD as well [1, 5] . The activation of these cells is often associated with an increased consumption of oxygen and leads to a generation of ROS through the activation of nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase resulting in "respiratory burst".
There are a lot of reports [3, 6, 7] indicating an increased ROS production during COPD. It is known, that a number of neutrophils and concentration of various proinflammatory markers is increased in bronchoalveolar lavage fluid (BALF) and induced sputum (IS) during COPD [8] [9] [10] . Moreover, it is hypothesized that COPD begins with biochemical and cellular events occurring at the tissue level, which quickly attack small airways and surrounding alveoli. By the time of clinical and X-ray signs of COPD are present, the disease is far advanced. The original attack is on the alveolar attachments of small airways that serve to tether airways [1, 11] . Thus, analysis of airways mucous, represented by BALF and IS, modulator effect may improve the knowledge of COPD pathogenesis. BALF and IS are biological fluids containing both cellular and acellular components [11] . The interface between their cellular composition and features of proinflammatory mediators are intensively investigated during COPD. While, a certain influence of airway mucous obtained from different parts of bronchi on ROS production in neutrophils during COPD is unknown.
Thus, the aim of our study was to elucidate if BALF and IS alone or in combination with chemical or biological stimulus influence ROS production in peripheral blood neutrophils during COPD. Furthermore, we aimed to analyse whether a modulator effect of airway mucous differs in neutrophils of COPD patients and HI.
Material and Methods

Study individuals
47 patients with stable COPD, according to GOLD (stage II-III) [1] were enrolled to the study. 14 nonsmoking HI with normal lung function were tested as a control group. The age of COPD patients (61.8±7.2) and HI (55.6±8.5) did not significantly differ. All COPD patients were without inhaled and systemic steroids for at least 1 month before the study and were ex-smokers for ≥2 years.
The study was approved by the Regional Bioethics Committee in Kaunas University of Medicine and written informed consent was received from all participants.
Neutrophil isolation from peripheral blood
Neutrophils were isolated from peripheral blood (EDTA anti-coagulated) of COPD patients and HI by a density gradient centrifugation. The blood was layered on Ficoll-Paque PLUS (GE Healthcare, Finland) and centrifuged at 10 o C for 30 min, 1000g. The cells below the Ficoll-Paque PLUS (containing erythrocytes and granulocytes) were lysed with distilled water. The lysis was repeated until complete erythrolysis. An obtained granulocyte suspension was washed with RPMI 1640 (Biological Industries, Israel). The cells were used at a final concentration of 4x10 6 cells/ml for stimulation with phorbol-myristate-acetate (PMA) and 8x10 6 cells/ml for stimulation with Staphylococcus aureus (S. aureus) bacteria. The viability of neutrophils was checked flow cytometrically and it always was >95% ( Figure 1 ).
BALF and IS samples
BALF and IS samples were prepared according to ERS guidelines [12] . Briefly, to perform bronchoscopy, the bronchoscope (Olympus, USA) was wedged into the segmental bronchus of the middle lobe and 140 mL of sterile 0.9% NaCl was infused. Fluid was gently aspirated immediately after the infusion and collected into a sterile container. Sputum induction was performed using ultrasonic nebulizer (DeVilbiss Health Care, USA) via inhalation of 3% sterile hypertonic saline solution (Ivex Pharmaceuticals, USA). Followed by 5 min. inhalation, patients were encouraged to cough an adequate amount of sputum. R1 -a population of viable neutrophils, R2 -a population of non-viable neutrophils. SSC -side scater represents the granularity, complexity of the cells), FL-3 -red fluorescence channel, 620 nm emission. ROS generation was analyzed in neutrophils, represented by R1.
BALF and IS samples were processed immediately after recovery or sputum expectoration. Suspensions were centrifuged within 20 min., 200g and supernatants were stored at -70 o C. In order to assure the same conditions for experimental ROS analysis, pooled and filtered BALF and IS supernatants of 20 COPD patients were used.
To avoid a possible interfere due to hypertonic saline solution, used for sputum induction, an osmotic pressure of IS was checked using osmometer (Loeser Messtechnik, Germany). Osmolality of pooled IS diluted in RPMI (1:1), as it was used for the experiments, was 304 mOsm/L and did not exceed physiological range [13] .
ROS generation in vitro
Modified ROS generation tests were performed in 96-well round-bottom microtiter plates (Falcon, BD, USA). Each well was pre-filled with 60 µl of isotonic Percoll (GE Healthcare, Finland) in order to avoid adherence and loss of activated neutrophils. Then ROS stimulating factors were added: (1) PMA (Sigma-Aldrich, Germany) at final concentrations between 0.1 and 30 nM alone or in combination with BALF (1:1) and IS (1:1) or (2) killed and fixed S. aureus bacteria (Pansorbin, Calbiochem, Germany) at a ratio of 0.7-500 bacteria per neutrophil (bact/neutrophil) alone or in combination with BALF (1:1) and IS (1:1). PMA alone and non-opsonized bacteria served as a controls. Some bacteria were opsonized with 10% human serum. BALF diluted 1:1 with RPMI (BALF/RPMI) and IS diluted 1:1 with RPMI (IS/RPMI) was used to investigate the direct influence of these fluids on ROS production in neutrophils. Neutrophil suspensions (60 μl) were overlaid and plates were incubated in a humidified atmosphere at 37 o C, 5% CO 2 for 45 min. with PMA and 3 h with S. aureus bacteria. For the detection of generated ROS the non-fluorescent dye dihydrorhodamine-123 (DHR-123, Invitrogen, USA) was added to the suspensions. DHR-123, by interaction with intracellular ROS is oxidized to the green-fluorescent rhodamine-123 (catalyzed by cellular myeloperoxidase).
All set-ups were made in duplicate. The relative amount of generated ROS was measured by flow cytometry by determination of the mean green fluorescence intensity of gated neutrophil populations after acquisition of 10 4 cells in total. The production of ROS without any stimulation served as negative control.
Flow cytometry
Flow cytometric measurements were performed with a FACSCanto (Becton Dickinson, USA) cytometer. For each determination at least 10 4 events were acquired. Characteristic forward (size, FSC-A) and side scatter (granularity, complexity, SSC-A) properties of neutrophilic granulocytes served to determine the purity of cellular suspensions and to monitor morphological changes after incubations and stimulations with tested substances. Total numbers of viable neutrophils were quantified and identified by addition of propidium iodide (PI, 2 mg/ml final, Calbiochem, Germany), which stains deoxyribonucleic acid of dead cells. Data were analyzed with the software WinMDI, version 2.9 [14] .
Chemicals used for ROS stimulation
The phorbol ester PMA (Sigma-Aldrich, Germany) was used at final concentrations between 0.1 and 30 nM diluted in RPMI 1640. Working solutions were made from Stock solution diluted in dimetilsulfoxid. Killed and fixed S. aureus (Pansorbin, Calbiochem, Germany) bacteria were opsonized with pooled and inactivated (56 o C, 1 h) human serum. A culture medium for in vitro assays RPMI 1640 (Biological Industries, Israel) was suplemmented with 100 U/ml penicillin, 100 µg/ml streptomycin, 15 mM HEPES, 7 mM NaHCO 3 . Non-fluorescent dye DHR-123 (Invitrogen, USA) was used at final concentration of 750 ng/ml.
Statistical analysis
Statistical analysis was performed using SPSS 12.0 for Windows. Data was expressed as the mean ± standard error of mean (SEM).
Differences between all observations were explored using one-way ANOVA followed by Kruskal-Wallis test. Nonparametric two-tailed Mann-Whitney test for unpaired observations was used to assess the statistical significance of differences between the groups. A p-value <0.05 (p<0.05) was considered significant.
Results
Characteristics of study individuals
Lung function parameters were lower in COPD group, compared to HI (respectively, forced expiratory volume in 1 second (FEV 1 ) (% pred.) -54.7±4.1 and 112.4±6.4; forced vital capacity (FVC) (% pred.) -70.3±7.6 and 108±6.9; FEV 1 /FVC ratio 52.8±5.4 and 92.5±3.7, p<0.05).
Cellular composition of BALF and IS used for ROS modulation
The total cell number of pooled BALF was 1.12±0.6x10 6 / ml, IS -0.61±0.2x10 6 /ml. The detailed composition of inflammatory cells is described in previous our manuscript [8] . The predominance of macrophages was obtained in BALF, while neutrophils were more obvious in IS samples.
Spontaneous and PMA induced ROS production in peripheral neutrophils
The spontaneous production of ROS was 27.7±4.3% (p<0.05) higher in neutrophils from COPD group than HI. PMA stimulated ROS generation in dose-dependant way both in COPD patients and HI. The production of ROS was more intensive in neutrophils obtained from COPD patients (p<0.05). The most significant difference between increased ROS generation was found at low stimulus concentrations (0.3-1.0 nM) of PMA both in COPD patients (84.7-fold) and HI (43.2-fold) (Figure 2) . The production of ROS reached plateau at 3.0 nM PMA. Total, PMA induced ROS production increased 172.3-fold in COPD patients and up to 141.4-fold in HI, compared to basal conditions (100% RPMI).
Opsonized S. aureus induced higher ROS
production in peripheral neutrophils than non-opsonized bacteria S. aureus bacteria stimulated ROS generation in dosedependant way both in COPD patients and HI, as well as PMA. The production of ROS in most bacteria concentrations was more intensive in COPD group (p<0.05), compared to HI (Figure 3) .
Opsonized bacteria induced a higher ROS production than non-opsonized bacteria (p<0.05), especially at higher concentrations (6-500 bact/neutrophil) -14.5-fold at 56 bact/neutrophil in COPD group and 13.2-fold at 167 bact/neutrophil in HI. The highest dose-dependant increase in COPD patients was obtained between 2-6 bact/neutrophil concentrations of opsonized bacteria (7.9-fold). Such increase in HI was observed between higher concentrations than in COPD group -at 6-18 bact/neutrophil (5.5-fold).
The dose-dependant increase of ROS, stimulated by non-opsonized and opsonized bacteria, was lower and less intensive in HI compared to COPD patients (p<0.05).
BALF stimulates low PMA concentrations and non-opsonized bacteria induced ROS production
BALF/RPMI stimulated ROS production both in COPD patients and HI ( Figure 4) . Also, BALF combination with low PMA concentrations (0.1-0.3 nM) stimulated ROS generation (p<0.05) as well ( Figure 5 ). The highest increase was obtained at combination of BALF with 0.3 nM PMA -42.1±5.6-fold in COPD group and 28.2±7.1-fold in HI, compared to PMA alone. BALF combination together with higher PMA concentrations (1.0-30 nM) caused inhibition of ROS production in both groups. The most significant inhibitory effect of BALF on ROS production was observed at 10 nM PMA -29.6±6.3-fold in COPD group and 12.5±7.8-fold in HI, compared to PMA alone. Also, BALF stimulated bacteria induced ROS production, especially in combination with higher bacteria concentration (6-500 bact/neutrophil) in dose-dependant way (p<0.05) ( Figure 6 ). The highest stimulatory effect of BALF was obtained at 6 bact/neutrophil S. aureus in COPD group (7.1±1.8-fold) and at 18 bact/neutrophil in HI (8.3±1.6-fold), compared to S. aureus alone. Moreover, BALF in combination with low concentrations of S. aureus (0.7-2 bact/neutrophil) had a tendency to stimulate ROS even compared to opsonized S. aureus bacteria. The inhibitory BALF effect, compared to opsonized bacteria, was observed at higher than 18 bact/neutrophil concentrations ( Figure 6 ).
IS inhibits PMA induced, but not nonopsonized bacteria induced ROS generation
IS/RPMI inhibited ROS production both in COPD patients and HI (p<0.05) (Figure 4 ). When used with PMA (0.1-30 nM), IS had also a dose-dependant induction of ROS, but it was lower at all PMA concentrations, compared to PMA alone (p<0.05) (Figure 7) . The highest inhibitory effect in both groups was observed together with 3.0 nM PMA -129.6±19.7-fold (COPD group) and 98.4±13.1-fold (HI), compared to PMA alone. Plateau was also reached at 3.0 nM PMA. Unlike combination with PMA, IS together with nonopsonized bacteria (2-500 bact/neutrophil) stimulated (p<0.05) or had a tendency to stimulate ROS production ( Figure 6 ). The highest IS stimulatory effect for ROS generation was obtained together with 6 bact/neutrophil concentration in COPD group (4.1±1.5-fold) and with 56 bact/neutrophil in HI (5.3±2.8-fold). Plateau was reached together with 167 bact/neutrophil S. aureus concentration.
Compared to opsonized bacteria, IS in combination with 6 bact/neutrophil and higher bacteria concentrations inhibited ROS production (p<0.05) (Figure 6 ). IS combination with lower bacteria concentrations had no significant effect on ROS production, but a tendency of ROS suppression was seen. The highest IS inhibitory effect on ROS generation was compared to 56 bact/ neutrophil of opsonized bacteria -11.1±2.8-fold (COPD group) and 4.9±2.4-fold (HI).
Discussion
Our study was designed to elucidate a possible direct effect of airway mucous on ROS production in peripheral blood neutrophils during COPD. For this purpose, a modified ROS generation in vitro was used. A detection of ROS production at a single cell level was performed using a sensitive DHR-123 staining, which detects ROS production at a single cell level. The modulatory effect of biological fluids, obtained from different parts of bronchi, was also investigated in combination with dose-dependant intensity of chemical and biological ROS stimulating factors.
A more intensive spontaneous ROS production in circulating neutrophils of COPD patients demonstrated an increased neutrophil activity during inflammation, which is obvious to COPD. It is well known that activated neutrophils release a variety of proinflammatory markers leading to a local and systemic cell and tissue damage [5, 15, 16] . Majority of intracellularly produced ROS are released to extracellular space and pass to cytosol of adjacent cells [17] . Thus, ROS generated by a single activated neutrophil, is able to influence other cells and amplificate an inflammation in this way.
Both chemical and biological ROS stimulating factors caused a higher ROS generation in COPD patients than in HI. Previous studies [18, 19] have also suggested that a balance between inflammation mediated oxidative damage to tissues and oxidant induced protective mechanisms is maintained in HI. Otherwise, a persistent activity of neutrophils, caused by ROS, may interrupt this balance and lead to chronic illness in the future. In addition, a more intensive ROS production in neutrophils of COPD patients, suggests a possible pre-stimulation of neutrophils during inflammation, which is absent in HI.
Such pre-stimulation and sensitiveness of neutrophils may be caused by a variety of pro-inflammatory cytokines, disturbed protease/antiprotease balance [1, 8, 15, 16] and other inflammatory mechanisms.
PMA is an artificial stimulus, which induces ROS production through the activation of protein kinase C (PKC). It further stimulates NADPH-oxidase and increases production of endogenous hydrogen peroxide, which causes an oxidative stress in the cells [20] . Bacteria represent a biological stimulus for ROS induction. Else, more intensive ROS production induced by opsonized bacteria in both studied groups, is explained by activated NADPH-oxidase via Fc and complement receptors binding.
The most important finding, extending the importance of our study, was a modulatory effect of BALF and IS on ROS production. A co-stimulatory effect of BALF in combination with relatively low PMA stimulus and nonopsonized bacteria was obtained. Moreover, together with relatively low concentrations of S. aureus, BALF showed a tendency to co-stimulate ROS even compared to opsonized bacteria.
Conversely, in presence of relatively high chemical and biological stimulus, BALF acted as an inhibitor for ROS generation. Such data may suggest an increased activity of cellular defences against ROS formation. It is important to note, that in our experimental model the concentration of BALF remained the same and only the intensity of chemical or biological stimulus was changed.
IS modulated ROS production, as well. Moreover, in most cases this effect was stronger in COPD group than in HI. In contrast to BALF, IS alone and in presence of chemical stimulus inhibited ROS generation. Interestingly, together with non-opsonized S. aureus bacteria, IS co-stimulated ROS production. As this effect was lower compared to opsonized bacteria, it suggests, that components of IS may influence ROS synthesis mediated by Fc receptors, but are not able to activate PKC or complement proteins.
In addition, a modulatory effect of IS in combination with chemical stimulus was stronger than BALF. A possible explanation may be higher concentration of various proteins (both pro-and anti-inflammatory) in IS compared to BALF. Previous our studies (unpublished data), showed a higher concentration of inflammatory mediators (IL-8, IL-5, eotaxins, leukotriens etc.) in IS than in BALF both in COPD patients and HI. However, the aim of our study was to analyse the direct influence of BALF and IS itself, but not the impact of their components. There are some hypotheses showing an increased neutrophil activity in IS due to hypertonic saline solution used for sputum induction [21] [22] [23] .
Importantly, the osmolality of our IS sample, which was used to modulate ROS production did not exceed its physiological concentrations [13] . Thus, the modulatory effect of IS should not be influenced by hypertonic saline solution in our study.
An inhibitory effect of BALF and IS on ROS generation suggests a prolonged activation of inflammatory cells due to impaired apoptosis. Thus, the cells remain active and continue to release proinflammatory mediators for a longer time [24, 25] . Moreover, an impaired apoptosis may lead to neutrophils migration towards pulmonary circulation and adherence to endothelial cells in the alveolar wall before passing into the alveolar space [26] .
ROS modulation by BALF and IS may be also explained by different airway compartments, which are represented by these biological fluids. Digital imaging has shown that BALF represents more distal airway and alveolar events [27] , whereas IS -larger airways, containing higher percentages of neutrophils and lower percentages of macrophages than BALF [27, 28] . Thus, a different nature of these fluids may account for a separate mechanism of action and pathways involved in ROS generation.
According to pathophysiology of COPD, the major site of airflow limitation is in the smaller conducting airways [1, 12] . Therefore, chronic inflammation causes structural changes and narrowing of the small airways, which are represented by BALF. Thus, ROS stimulatory effect by BALF may not be excluded from initiation of these pathological effects as well.
Else, an activation of NADPH-oxidase through PKC signalling system, together increases phosphorylation of tyrosine and tyrosine kinase inhibitors block "respiratory burst" [29] . Thus, in presence of higher chemical and biological stimulus, BALF and IS may interfere PKC activation pathways or activate tyrosine kinase inhibitors and result in ROS inhibition in peripheral blood neutrophils.
In conclusion, BALF and IS are able directly modulate ROS production in absence of chemical or biological ROS stimulating factors. Furthermore, our data suggest that these biological fluids influence ROS production through the activation of different receptors and mechanisms. It may be influenced by direct BALF and IS interaction with NADPH-oxidase or Fc-receptors activation.
Modulatory effect, which is stronger in neutrophils obtained from COPD patients, is dependant on stimulus origin and concentration, suggesting a pre-stimulation and sensitiveness of neutrophils during chronic inflammation.
